SCHEMBL2352846

SCHEMBL2352846

O=S1(=O)CCC(C2CC2)c2ccc(Oc3ccc(F)cc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 5/20 0.42
VEGFA P15692 2/20 0.36
EPAS1 Q99814 1/20 0.34
MMP2 P08253 2/20 0.34
MMP9 P14780 2/20 0.34
MMP14 P50281 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
GRIA2 P42262 2/20 0.34
ABL1 P00519 1/20 0.34
ALOX5 P09917 1/20 0.33
SLC10A2 Q12908 1/20 0.33
MMP3 P08254 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KDM2B Q8NHM5 1/20 0.32
PARP14 Q460N5 1/20 0.32
PARP10 Q53GL7 1/20 0.32
SCN9A Q15858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2357565 0.88 GRIA2 (0.43) ADRA1DGRIA2SLC10A2
SCHEMBL2353944 0.88 GRIA2 (0.44) ADRA1DGRIA2SLC10A2
SCHEMBL2351722 0.87 MAOA (0.35) ADRA1DGRIA2
SCHEMBL2355589 0.84 ADRA1D (0.40) ADRA1DGRIA2
SCHEMBL2353940 0.83 GRIA2 (0.48) ADRA1DGRIA2SLC10A2
SCHEMBL2357409 0.82 GRIA2 (0.35) ADRA1DVEGFASLC6A2SLC6A4SLC6A3
SCHEMBL2353218 0.82 ADRA1D (0.46) ADRA1DGRIA2SLC10A2
SCHEMBL2354007 0.77 MMP2 (0.46) ADRA1DMMP2ALDH1A1
SCHEMBL2347270 0.73 GRIA1 (0.35) ADRA1DGRIA2ALDH1A1
SCHEMBL2354383 0.73 CA1 (0.36) ADRA1DGRIA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011083264-A1 THIOCHROMAN DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2011-07-14 WO disclosed